Tributyrin
Dietary Supplementa triglyceride containing three C4-acids
NCT Number: NCT02264951
This study compared the incretin-releasing effect of C8-diet oil and tributyrin with that of 20 ml olive oil on a molar basis in human volunteers.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
A structured triglyceride (1,3-di-octanoyl-2-oleoyl-glycerol, called C8-diet oil), which upon digestion results in generation of two medium-chain fatty acids and 2-oleoyl-glycerol (2-OG), may lead to activation of GPR119 only, since medium fatty acids are poor agonists for fatty acid receptors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a triglyceride containing three C4-acids
a triglyceride containing 2 C8-fatty acids and one oleic acid at sn-2 position
a triglyceride containing mostly three oleic acids
mainly water and glucose
Time frame: 2 hours postprandial
Time frame: 2 hours postprandial
Time frame: 2 hours postprandial
Time frame: 2 hours postprandial
Time frame: 2 hours postprandial
Time frame: 2 hour postprandial
Time frame: 2 hour postprandial
Glostrup University Hospital, Copenhagen
Other
Short Fatty Acids-induced Release of GLP-1 in Humans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT06649344
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT07732218
Diabetes Mellitus, Diabetes Mellitus, Type 2
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial Details